All Stories

  1. Candidozyma auris and the Perfect Storm of Fungal Pathogenicity: Adaptation, Persistence, and Resistance
  2. Insights into Persian Gulf Beach Sand Mycobiomes: Promises and Challenges in Fungal Diversity
  3. Antifungal Efficacy of Luliconazole-Loaded Nanostructured Lipid-Carrier Gel in an Animal Model of Dermatophytosis
  4. Clinical characteristics and outcomes of colonization and infection by yeast species in solid organ transplant recipients: Molecular identification and antifungal susceptibility patterns of isolates
  5. Metabolic Patterns of Fluconazole Resistant and Susceptible Candida auris Clade V and I
  6. An Autochthonous Susceptible Candida auris Clade I Otomycosis Case in Iran
  7. In-vivo efficiency of the novel azole compounds (ATTAF-1 and ATTAF-2) against systemic candidiasis in a murine model
  8. Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment
  9. In vitro combination of antifungal drugs with tacrolimus (FK506) holds promise against clinical Candida species, including Candida auris
  10. Potential Inhibitory Effect of Miltefosine against Terbinafine-Resistant Trichophyton indotineae
  11. The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)
  12. Confirmation of fifth Candida auris clade by whole genome sequencing
  13. Five Years Surveillance Study of Clinical and Environmental Triazole‐Resistant Aspergillus fumigatus Isolates in Iran
  14. In Vitro Antifungal Susceptibility Profile of Miltefosine against a Collection of Azole and Echinocandins Resistant Fusarium Strains
  15. Global prevalence and subgroup analyses of coronavirus disease ( COVID ‐19) associated Candida auris infections ( CACa ): A systematic review and meta‐...
  16. Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole
  17. Evaluating a semi‐nested PCR to support histopathology reports of fungal rhinosinusitis in formalin‐fixed paraffin‐embedded tissue samples
  18. South Asian (Clade I) Candida auris meningitis in a paediatric patient in Iran with a review of the literature
  19. Frequency of occurrence, seasonal variation and antifungal susceptibility of opportunistic Mucorales isolated from hospital soils in Iran
  20. In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes
  21. The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus COVID‐19 associated mucormycosis
  22. Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature
  23. Overexpression of Efflux Pump Genes is an Alternative Mechanism in Voriconazole Resistant Aspergillus fumigatus isolates Without Relative Mutations in CYP5A
  24. MixInYeast: A Multicenter Study on Mixed Yeast Infections
  25. Fatal Invasive Pulmonary Aspergillosis in COVID-19 Patient with Acute Myeloid Leukemia in Iran
  26. Clonal Expansion of Environmental Triazole Resistant Aspergillus fumigatus in Iran
  27. Opportunistic Fungal Infections in the Epidemic Area of COVID-19: A Clinical and Diagnostic Perspective from Iran
  28. First azole‐resistant Aspergillus fumigatus isolates with the environmental TR 46 /Y121F/T289A mutation in Iran
  29. Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates
  30. Highly Concentrated Multifunctional Silver Nanoparticle Fabrication through Green Reduction of Silver Ions in Terms of Mechanics and Therapeutic Potentials
  31. Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans/Cryptococcus gattii species complex
  32. Interactions between immune response to fungal infection and microRNAs: The pioneer tuners
  33. New potent antifungal triazole alcohols containing N-benzylpiperazine carbodithioate moiety: Synthesis, in vitro evaluation and in silico study
  34. In vitro activity of nine antifungal agents against a global collection of Hortaea werneckii isolates, the agent of tinea nigra
  35. A simple and low cost tetra-primer ARMS-PCR method for detection triazole-resistant Aspergillus fumigatus
  36. Airway colonisation by Candida and Aspergillus species in Iranian cystic fibrosis patients
  37. Candida auris otomycosis in Iran and review of recent literature
  38. Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles
  39. Epidemiology of Aspergillus species causing keratitis in Mexico
  40. Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis
  41. Comparative virulence of Candida auris with Candida haemulonii , Candida glabrata and Candida albicans in a murine model
  42. Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species
  43. In Vitro Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates
  44. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus : Should we be concerned?
  45. Evaluation of PCR-reverse line blot hybridization assay for simultaneous identification of medically important saprophytic fungi
  46. Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients
  47. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry
  48. Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Persian Gulf region: A case and review
  49. In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex
  50. Use of cell surface protein typing for genotyping of azole-resistant and -susceptible Aspergillus fumigatus isolates in Iran
  51. Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates
  52. Multicenter Identification and Antifungal Susceptibility Patterns of Candida Species Isolated from Clinical Samples
  53. A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study
  54. Coexistence of aspergilloma and pulmonary hydatid cyst in an immunocompetent individual
  55. Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus
  56. In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared with Those of Five Antifungal Drugs against Melanized Fungi and Relatives
  57. In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris
  58. Consistent high prevalence of Exophiala dermatitidis , a neurotropic opportunist, on railway sleepers
  59. Epidemiological and mycological characteristics of candidemia in Iran: A systematic review and meta-analysis
  60. Successful treatment with caspofungin of candiduria in a child with Wilms tumor; review of literature
  61. Whole Genome-Based Amplified Fragment Length Polymorphism Analysis Reveals Genetic Diversity in Candida africana
  62. Disseminated Nocardiosis in an Immunocompetent Individual Infected with Nocardia brasiliensis, an Opportunistic Agent
  63. Activities of Novel Azoles against Candida spp.
  64. Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata
  65. Is human dectin-1 Y238X gene polymorphism related to susceptibility to recurrent vulvovaginal candidiasis?
  66. Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus Strains
  67. Microdilution in vitro Antifungal Susceptibility Patterns of Candida Species, From Mild Cutaneous to Bloodstream Infections
  68. High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?
  69. Amino acid substitutions in Erg11p of azole-resistant Candida glabrata: Possible effective substitutions and homology modelling
  70. In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus , an opportunistic fungal pathogen
  71. In vitroactivity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates: Table 1.
  72. In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen
  73. Mucormycosis in Iran: a systematic review
  74. Genotyping of clinical and environmentalAspergillus flavusisolates from Iran using microsatellites
  75. Genetic and Morphological Diversity of the Genus Penicillium From Mazandaran and Tehran Provinces, Iran
  76. Coinfection of Pulmonary Hydatid Cyst and Aspergilloma: Case Report and Systematic Review
  77. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex
  78. Global Spread of Human Chromoblastomycosis Is Driven by Recombinant Cladophialophora carrionii and Predominantly Clonal Fonsecaea Species
  79. cyp51Agene silencing using RNA interference in azole-resistantAspergillus fumigatus
  80. Cryptococcal meningitis due toCryptococcus neoformansgenotype AFLP1/VNI in Iran: a review of the literature
  81. In VitroSusceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium
  82. Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran
  83. Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis
  84. Use of Padlock Probes and Rolling Circle Amplification (RCA) for Rapid Identification of Trichophyton Species, Related to Human and Animal Disorder
  85. Use of Restriction Fragment Length Polymorphism to Rapidly Identify Dermatophyte Species Related to Dermatophytosis
  86. Synthesis and biological evaluation of fluconazole analogs with triazole-modified scaffold as potent antifungal agents
  87. In vitrosusceptibility patterns of clinically importantTrichophytonandEpidermophytonspecies against nine antifungal drugs
  88. First fatal cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Iran, based on ITS rDNA
  89. Multilocus sequence typing of Candida albicans isolates from a burn intensive care unit in Iran
  90. Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis
  91. First Autochthonous Coinfected Anthrax in an Immunocompetent Patient
  92. Novel triazole alcohol antifungals derived from fluconazole: design, synthesis, and biological activity
  93. A reappraisal of orders and families within the subclass Chaetothyriomycetidae (Eurotiomycetes, Ascomycota)
  94. Imidazolylchromanones containing non-benzylic oxime ethers: Synthesis and molecular modeling study of new azole antifungals selective against Cryptococcus gattii
  95. Cladophialophora abundans, a novel species of Chaetothyriales isolated from the natural environment
  96. Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser
  97. Environmental study of azole‐resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran
  98. Chromoblastomycosis due to Fonsecaea pedrosoi and F. monophora in Cuba
  99. Severe Disseminated Phaeohyphomycosis in an Immunocompetent Patient Caused by Veronaea botryosa
  100. Use of Rolling Circle Amplification to Rapidly Identify Species of Cladophialophora Potentially Causing Human Infection
  101. Veronaea botryosa: Molecular Identification with Amplified Fragment Length Polymorphism (AFLP) and In vitro Antifungal Susceptibility
  102. An unusual case of eumycetoma caused byExophiala jeanselmeiafter a sea urchin injury
  103. In VitroAntifungal Susceptibility of Cladophialophora carrionii, an Agent of Human Chromoblastomycosis
  104. First case of disseminated phaeohyphomycosis in an immunocompetent individual due to Alternaria malorum
  105. Molecular characterisation and pathogenicity ofPhaeoacremoniumspp. associated with esca disease of grapevine in Northern Iran
  106. Molecular Tools in Medical Mycology; Where We Are!
  107. Epidemiology and molecular characterization of Cryptococcus neoformans isolated from pigeon excreta in Mazandaran province, northern Iran
  108. Multiple subcutaneous cysts due toExophiala spiniferain an immunocompetent patient
  109. Waterborne Exophiala species causing disease in cold-blooded animals
  110. Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist
  111. Cladophialophora psammophila, a novel species of Chaetothyriales with a potential use in the bioremediation of volatile aromatic hydrocarbons
  112. Exophiala sideris, a novel black yeast isolated from environments polluted with toxic alkyl benzenes and arsenic
  113. Melanization of a Meristematic Mutant of Fonsecaea monophora Increases Tolerance to Stress Factors While no Effects on Antifungal Susceptibility
  114. Fatal Cerebral Phaeohyphomycosis in an Immunocompetent Individual Due to Thielavia subthermophila
  115. Subcutaneous phaeohyphomycotic cyst caused by Pyrenochaeta romeroi
  116. Rhinocladiella aquaspersa , proven agent of verrucous skin infection and a novel type of chromoblastomycosis
  117. Use of Amplified Fragment Length Polymorphism To Identify 42 Cladophialophora Strains Related to Cerebral Phaeohyphomycosis with In Vitro Antifungal Susceptibility
  118. The clinical spectrum of Exophiala jeanselmei , with a case report and in vitro antifungal susceptibility of the species
  119. Successful treatment of chromoblastomycosis of 36 years duration caused byFonsecaea monophora
  120. In Vitro Activities of Eight Antifungal Drugs against 55 Clinical Isolates of Fonsecaea spp.
  121. First Autochthonous Case of Rhinocladiella mackenziei Cerebral Abscess Outside the Middle East
  122. In vitro activities of antifungal drugs against Rhinocladiella mackenziei, an agent of fatal brain infection
  123. In vitro activities of eight antifungal drugs against 70 clinical and environmental isolates of Alternaria species
  124. The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species
  125. Cladophialophorasaturnicasp. nov., a new opportunistic species ofChaetothyrialesrevealed using molecular data
  126. Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora
  127. Genetic diversity and species delimitation in the opportunistic genusFonsecaea
  128. Seroepidemiological Study for Toxocariasis among Children in Zanjan-Northwest of Iran
  129. Biodiversity of the genus Cladophialophora
  130. Tinea nigra by Hortaea werneckii, a report of 22 cases from Mexico
  131. Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species
  132. Fungal Contamination in Indoor Swimming Pools in Zanjan-Iran 2005